Expleo Solutions Ltd. - Research Center
533121 EXPLEOSOL Group (B) BSE data
Results
Statement
More
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Equity share capital
10.25 |
10.25 |
10.25 |
10.25 |
10.71 |
Share application money
Preference share capital
Reserves & surplus
457.53 |
198.59 |
149.58 |
104.87 |
96.04 |
Secured loans
Unsecured loans
Total
473.65 |
208.97 |
159.96 |
115.25 |
106.88 |
Gross block
183.82 |
61.32 |
45.02 |
41.31 |
30.60 |
Less : revaluation reserve
Less : accumulated depreciation
43.68 |
22.31 |
20.35 |
15.34 |
11.77 |
Net block
140.14 |
39.01 |
24.68 |
25.98 |
18.83 |
Capital work-in-progress
Investments
Current assets, loans & advances
484.59 |
248.16 |
199.50 |
153.85 |
136.01 |
Less : current liabilities & provisions
161.15 |
82.22 |
68.23 |
68.59 |
51.97 |
Total net current assets
323.44 |
165.94 |
131.27 |
85.26 |
84.04 |
Miscellaneous expenses not written
Total
473.65 |
208.97 |
159.96 |
115.25 |
106.88 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
110.85 |
93.65 |
92.25 |
90.72 |
89.49 |
Number of equity sharesoutstanding (Lacs)
102.52 |
102.52 |
102.52 |
102.52 |
107.13 |